2024-ISS-262_SS_1912_Att_A.pdf

PDF 288 KB Posted

Attached to
VectoLex and VectoBac Products for Mosquito-Control
Solicitation number
2024-ISS-262
Issued by
Sarasota County, Siesta Key CDP, Florida

About this file

This is an Exemption Revision Form and Sole Source Form for Sarasota County's Health & Human Services Department, specifically the Mosquito Management division, seeking to renew a sole source procurement with ADAPCO LLC for VectoLex and VectoMax mosquito control products from Valent BioSciences LLC. The contract will cover individual purchases of VectoLex FG and VectoLex WDG products for mosquito control, with the goal of continuing the County's Mosquito Management Integrated Pest Management Plan. The procurement is for a three-year period from 10/09/2024 to 10/08/2027, with an estimated expenditure increase from $80,000.00 to $120,000.00 per fiscal year.

Valent BioSciences LLC is identified as the sole manufacturer of these specific mosquito control products, with ADAPCO LLC as their exclusive distributor in the United States. The products are designed to assist in reducing mosquito-borne disease risks and will provide a rotation of pesticide use to reduce potential mosquito resistance. The justification emphasizes that while other vendors may exist, these specific VectoLex products have shown a 7.5% active ingredient success rate in local mosquito populations and offer unique treatment capabilities that other products do not, such as allowing treatment in areas with woodlands and swamps without requiring citizens to avoid the area for four hours after application.

View the file

Other files

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

���������� ��
������

���&�0�� %��#��&!1 ������+��&2!

3�&����&�# %�4���- ���&�0�� %��#��&!1 ���&�0�� %��#��&!1 4.

5671777-77 5871777-77 5��71777-77 1 �797�9�7�6 �79789�7�: -��

��'���-&.)�$/�*. ��!�01!��2��+����3��))�) .��%�$�.�)�4.��%*.�5�.6/�)�$��7� �$ /&$(6�*&�/�)�8�/�)*�%�)�����$�)

)&+,�)-�/�.�$%,�!&+(�0,%�1,(2!�+,�&,�+%,#� )&+,�)-�/�.�$%,�!&+(�"%)�!()�����#"% �&����3�+%)"+1)�+(�+,�&,�+%,#�#"% "#�1,(2!�+,�$,$!#"+�,�(����')()�$%,�!&+(�"%)�"#(,�!()��+,�&,�+��!)�4,(2!�+,�4"�"3)1)�+5(� �+)3%"+)�� )(+�4"�"3)1)�+� #"��0,%�+')�$!6#�&��� ��"���+�,��� )&+,�)-�/�.�*�##�$%, ��)�"�%,+"+�,��,0�$)(+�&��)�!()�+,�%)�!&)�+')�$,+)�+�"#�,0�1,(2!�+,�%)(�(+"�&)�+,�$)(+�&��)(���

���/0������ .
��%1�12-�������)$���34/-� ����������5�������

�6����5������ ����(�

����������7�������-����� ���+
���6��.�����2� ��(�

���+��8�����(� ���+�9�8�

����7� ������
��5� �����:��*���;�� ��2����������-���

�2��

����� �� ���� ,��9������ ����(��������.�2���2��� ��
��6�������������

-��� ;�� ������5���� ��� ����.� ���� �

�����������
�����;�� ��

��� ��� �7� ����3,1<�� �6����5������ ��*�)� � -� ������)$���34/,��&������ ���-�� ���� �������

��������;����� �� �
� �=��������
� ����� ��� ����� ��� ��� ������*���*��������,��9� �����5��������*�7����������7��
�2���5� ��� ���*��;��� �.��������� ������ .�7� �� ����
-� �����6�����7������� �2���2��� ��
�� ������ �.� �� ��������-�
��2�.�
���5������� ����:� ������6�����,����.-�� ����

���� ������:� -�������5� �����7� �� ������������� �� ��� ��*��5��

�� ����������������6�
�-���6�� ���
������2� ���+�� �7� ������**���� �2�
�����,�$��� .

�� ��2� ��2� ����������7������� �����7�*��� ����� � �����*�

��
������-�7��
����

���6��5��� ;�� ������5���� > �&� �5�� ����� �����5���� �����,

������
���� ���
�����
����������������
���� �����������������
������������� � ! �!� � "���#

November 1, 2023

ATTN: Jason Trumbetta, ADAPCO LLC

RE: 2024 sole source notification

To Whom It May Concern:

This letter is to advise you that Valent BioSciences, LLC is the sole manufacturer and registrant of the trademarked product brands VectoBac® (Bacillus thuringiensis subsp. israelenis strain

AM65-52), VectoLex® (Bacillus sphaericus 2362 strain ABTS-1743), VectoMax® (Bacillus thuringiensis subsp. israelenis strain AM65-52 + Bacillus sphaericus 2362 strain ABTS-

1743), Bactimos® (Bacillus thuringiensis subsp. israelenis strain AM65-52), MetaLarv® and

VectoPrime®. This includes the formulations VectoBac G, VectoBac GS, VectoBac GR, VectoBac 12AS, VectoBac WDG; VectoLex FG, VectoLex WDG, VectoLex WSP;

VectoMax FG and VectoMax WSP; Bactimos PT, Bactimos WG; MetaLarv S-PT, MetaLarv

XRP; and VectoPrime FG.

Also, be advised that ADAPCO, LLC is Valent BioSciences LLC's sole authorized distributor for VectoBac®, VectoLex®, VectoMax®, Bactimos®, VectoPrime® and MetaLarv® products in the United States, Cayman Islands and Puerto Rico.

Should you have any questions regarding this information, feel free to contact me.

Regards, DDreww Hunterr

Drew Hunter | Manager, National Sales – Public Health

1910 Innovation Way | Libertyville, Illinois 60048 Phone: 503-983-6508 drew.hunter@valentbiosciences.com www.valentbiosciences.com

RE: 2024 sole source notification

SS 1912 Rev4
SS 1912 Unity
SS 1912 SS Letter

File details come from the government source that posted it. Updated .